Nek2 as a novel molecular target for the treatment of breast carcinomaNobuyuki Tsunoda, Michinari Hamaguchi, Toshio Kokuryo et al.|Cancer Science|2008Cited by 111
Tumor necrosis factor α promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2Yoko Tanimura, Michinari Hamaguchi, Yi-Yin Jan et al.|Cancer Letters|2004Cited by 59
SIRPα1 and SIRPα2: Their role as tumor suppressors in breast carcinoma cellsYukiko Yamasaki, Michinari Hamaguchi, Satoko Ito et al.|Biochemical and Biophysical Research Communications|2007Cited by 10
Cytoplasmic expression of the JM403 antigen GlcA-GlcNH 3 + on heparan sulfate glycosaminoglycan in mammary carcinomas—a novel proliferative biomarker for breast cancers with high malignancyMasahiro Fujii, Mamoru Kyogashima, Yoshiko Itoh et al.|Glycoconjugate Journal|2010Cited by 6
An awareness survey of surgeons involved in breast cancer treatment regarding their patients returning to work.Kazuhisa Akahane, Masato Nagino, Nobuyuki Tsunoda et al.|PubMed|2014Cited by 6